• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维拉帕米系列钙阻滞剂对实验性动脉高血压心肌线粒体活性的影响。

Effect of calcium blocking agents of the verapamil series on the myocardium mitochondrial activity in experimentally induced arterial hypertension.

作者信息

Niţă V, Serban M G, Wawernia E

机构信息

C. Davilla University of Medicine and Pharmacy, Department of Physiopathology, Bucharest, Romania.

出版信息

Rom J Intern Med. 1992 Oct-Dec;30(4):305-10.

PMID:1299423
Abstract

Some mitochondrial biochemical parameters were determined in Wistar rats with experimentally induced arterial hypertension (AHT) treated with calcium blocking agents of the Verapamil series. The results obtained showed that succinic dehydrogenase (SDH) activity increased, in the group with AHT, by 23.4% as compared with the control group while in the group with AHT treated with Verapamil the activity of this enzyme increased by 46.7%. The NAD+ dehydrogenase activity showed a moderate increase (15.7%) in the group with AHT and an increase by 22.3% after administration of Verapamil. The mitochondrial content in thiolic groups presented an increase of 12.5% in the group with AHT and of 24.4% in the treated group. The kinetics of the mitochondrial swelling-contraction also presented changes in as much as the cycle period, first increased then partially returned to normal values after Verapamil treatment. The strongly stimulating effect of Verapamil on the enzymatic activity in the Krebs cycle was also demonstrated.

摘要

在实验性诱导动脉高血压(AHT)的Wistar大鼠中,测定了一些线粒体生化参数,这些大鼠用维拉帕米系列钙阻滞剂进行治疗。所得结果表明,与对照组相比,AHT组的琥珀酸脱氢酶(SDH)活性增加了23.4%,而在用维拉帕米治疗的AHT组中,该酶的活性增加了46.7%。NAD+脱氢酶活性在AHT组中适度增加(15.7%),在给予维拉帕米后增加了22.3%。硫醇基团中的线粒体含量在AHT组中增加了12.5%,在治疗组中增加了24.4%。线粒体肿胀-收缩的动力学也出现了变化,因为循环周期先是增加,然后在维拉帕米治疗后部分恢复到正常值。还证实了维拉帕米对三羧酸循环中酶活性有强烈的刺激作用。

相似文献

1
Effect of calcium blocking agents of the verapamil series on the myocardium mitochondrial activity in experimentally induced arterial hypertension.维拉帕米系列钙阻滞剂对实验性动脉高血压心肌线粒体活性的影响。
Rom J Intern Med. 1992 Oct-Dec;30(4):305-10.
2
Verapamil attenuates calcium-induced mitochondrial swelling and respiratory dysfunction.
J Pharmacol Exp Ther. 1995 Apr;273(1):206-12.
3
Influence of alpha-tocopherol on doxorubicin-induced lipid peroxidation, swelling and thiol depletion in rat heart mitochondria.α-生育酚对阿霉素诱导的大鼠心脏线粒体脂质过氧化、肿胀及巯基消耗的影响。
Indian J Exp Biol. 1993 Mar;31(3):297-8.
4
Effect of vitamin D deficiency and 1,25-dihydroxyvitamin D3 on rat heart metabolism.维生素D缺乏及1,25-二羟维生素D3对大鼠心脏代谢的影响。
J Mol Cell Cardiol. 1994 Nov;26(11):1421-8. doi: 10.1006/jmcc.1994.1161.
5
Regulation of succinic dehydrogenase activity of heart mitochondria by anti-arrhythmic drugs.
Res Commun Chem Pathol Pharmacol. 1975 May;11(1):89-97.
6
Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.熊去氧胆酸对四氧嘧啶诱导的糖尿病大鼠肝脏线粒体功能的保护作用:与氧化应激的联系
Life Sci. 2007 Jun 6;80(26):2397-402. doi: 10.1016/j.lfs.2007.02.042. Epub 2007 Mar 12.
7
Possible mechanism of action of piperazine derivatives on liver mitochondria. I--Effect of p-toluyl m-nitro-piperazine (p-TNP).哌嗪衍生物对肝脏线粒体的可能作用机制。I - 对甲苯基间硝基哌嗪(p-TNP)的作用
Res Commun Chem Pathol Pharmacol. 1981 Oct;34(1):115-26.
8
[Protective effects of taurine on myocardial mitochondria and their enzyme activities in rate with severe burn].牛磺酸对重度烧伤大鼠心肌线粒体及其酶活性的保护作用
Zhonghua Shao Shang Za Zhi. 2008 Jun;24(3):171-4.
9
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.阿霉素诱导的累积性和不可逆性心脏线粒体功能障碍。
Cancer Res. 2001 Jan 15;61(2):771-7.
10
Influence of calcium on NADH and succinate oxidation by rat heart submitochondrial particles.钙对大鼠心脏亚线粒体颗粒氧化NADH和琥珀酸的影响。
Arch Biochem Biophys. 1995 Feb 1;316(2):815-20. doi: 10.1006/abbi.1995.1109.